These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4784489)

  • 1. Relationship between rifampicin-dependent antibody scores, serum rifampicin concentrations and symptoms in patients with adverse reactions to intermittent rifampicin treatment.
    O'Mahony MG; Kar CW
    Clin Allergy; 1973 Dec; 3(4):353-62. PubMed ID: 4784489
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity to rifampicin: incidence, mechanism, and prevention.
    Pujet JC; Homberg JC; Decroix G
    Br Med J; 1974 May; 2(5916):415-8. PubMed ID: 4835299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [2 cases of hemolytic complications during intermittent treatment with rifampicin].
    Năstase M; Brener E; Năstase R; Borgovan L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(1):43-6. PubMed ID: 171722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological aspects of adverse reactions during treatment with rifampicin].
    Zeană C; Bănică D; Algeorge G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(1):33-7. PubMed ID: 6264568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic reactions to intermittent rifampicin.
    Riska NV; Mattson K
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():280-5. PubMed ID: 4468024
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renal complications after rifampicin].
    Mănescu N; Dumitru S; Gluhovschi G; Golea O; Nicolcioiu M; Schwarzkopf A; Bercovici L; Hoţa F; Hoborca A; Zosin C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(1):35-42. PubMed ID: 171721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent renal failures in continuous treatment with rifampicin].
    Löllgen H; Bolte JP
    Munch Med Wochenschr; 1973 May; 115(20):913-5. PubMed ID: 4740450
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recurrent hemolytic accidents of immuno-allergic origin during intermittent treatment with rifampicin].
    Sors C; Sarrazin A; Homberg JC
    Rev Tuberc Pneumol (Paris); 1972; 36(3):405-16. PubMed ID: 5080967
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute renal failure after rifampicin (author's transl)].
    Mănescu N; Gluhovschi G; Golea O; Nicolcioiu M; Schwarzkopf A; Zosin C
    MMW Munch Med Wochenschr; 1974 Dec; 116(49):2161-6. PubMed ID: 4216838
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of adverse reactions in pulmonary tuberculosis patients treated with rifampicin].
    Anastasatu C; Dinulică E; Algeorge G; Cărpinişan L; Varga E; Rudescu D
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(4):213-9. PubMed ID: 174177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoallergic complication induced by rifampicin with disseminated intravascular coagulation].
    Denis J; Robert A; Johanet C; Homberg JC; Opolon P; Levy VG
    Presse Med; 1983 May; 12(23):1479-81. PubMed ID: 6222344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proceedings: Rifampicin adverse effects in intermittent therapy].
    Herrmann H; Eule H; Lau W; Kuhnert R; Fanter D; Kahlau U; Schönert E; Werner E
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):146-58. PubMed ID: 4491712
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute renal failure after rifampicin (author's transl)].
    Germann HJ; Hoppe-Seyler GF; Boesken WH
    Dtsch Med Wochenschr; 1974 Jul; 99(27):1454-7. PubMed ID: 4843503
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute renal failure during intermittent rifampicin therapy.
    Campese VM; Marzullo F; Schena FP; Coratelli P
    Nephron; 1973; 10(4):256-61. PubMed ID: 4573698
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Clin Allergy; 1974 Mar; 4(1):1-12. PubMed ID: 4824569
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of age and sex on the incidence of the 'flu' syndrome and rifampicin-dependent antibodies in patients on intermittent rifampicin for tuberculosis.
    Tubercle; 1975 Sep; 56(3):173-8. PubMed ID: 766339
    [No Abstract]   [Full Text] [Related]  

  • 17. [Presence of antibodies against rifampicin in patients under tuberculostatic treatment].
    Ion N; Jemma I; Sfetcu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(1):39-42. PubMed ID: 6264569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe immunoallergic reaction in a patient treated for two months continuously with rifampicin].
    Fardet L; Lalande V; Meyohas MC; Frottier J; Meynard JL
    Presse Med; 1999 Nov; 28(37):2037-8. PubMed ID: 10605471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations of allergic status and blood counts in Chinese patients receiving daily or intermittent rifampicin in Hong Kong.
    Clin Allergy; 1975 Jun; 5(2):189-99. PubMed ID: 1095248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H; Werner E; Winsel K; Iwainsky H
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.